This country profile provides an overview of Algeria’s progress in reaching those in need of mass NTD treatment based on 2019 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Treatment coverage

Elephantiasis
N/A
Blinding trachoma
0%
Intestinal worms
N/A
Bilharzia
N/A
River blindness
N/A
Zero people received treatment in Algeria in
2019
5,000 people did not receive treatment in in Algeria in 2019

Elephantiasis

Algeria does not require mass treatment for elephantiasis.

Blinding trachoma

Treatment coverage was decreased from 26% in 2018 to 0% in 2019.

People needing treatment
5,000
People receiving treatment
No data

Intestinal worms

Algeria does not require mass treatment for intestinal worms.

Bilharzia

Algeria does not require mass treatment for bilharzia.

River blindness

Algeria does not require mass treatment for river blindness.